An interventional study of Modified Constraint Induced Movement Therapy in Hemiplegia, Cerebral Palsy Spastic Hemiplegic and Acquired Brain Injury (Including Stroke), sponsored by University of Calgary. Enrolling by invitation at 1 site in Canada. Open to participants aged 5 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-05-01.
Sponsored by University of Calgary · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Hemiplegia with a site in Canada — 2 open to participants now, 2 under way, none of them phase 3. Hemiplegia · Canada.
Among the 10 studies in Hemiplegia with a site in Canada, this one is the only one that started in 2025, is one of 9 with no phase, and was the 10th registered.
450 studies on the registry are indexed under Hemiplegia; 92 are open to participants now.
Browse Hemiplegia studies →2 of the 10 studies in Hemiplegia with a site in Canada are open now. Recruiting first, the newest first:
The Hospital for Sick Children · Sites in Canada
Ages up to 18
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 59 Hemiplegia studies recruiting now, 16 (27%) set no upper age limit and 31 (53%) stop at 75 or younger; 9 take children under 18; 7 take healthy volunteers.
This study: 5 Years to 17 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2025.
This study's planned enrollment of 40 is above the median of 34 across 373 interventional studies indexed under Hemiplegia.
Median enrollment 26 across the 9 interventional studies, 12,000 across the 1 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 10 has an industry lead sponsor. The 8 most frequent:
University of Calgary is the lead sponsor of 704 studies on the registry; 197 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.
University of Calgary has 2 studies filed under Hemiplegia — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Hemiplegia with a site in Canada, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Our primary aim is to evaluate the implementation cost of a full day modified constraint induced movement therapy camp for children with hemiparesis.
Participants will complete a day camp (9am to 4pm) with constraint induced movement therapy in Week 1 and bimanual therapy in Week 2.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Constraint Induced Movement Therapy and Bimanual Therapy
Behavioral: Modified Constraint Induced Movement Therapy
Constraint Induced Movement Therapy and Bimanual Therapy
Implementation Cost
Implementation cost covers all resources necessary, including personnel, time, space, and supplies.
Time frame: From enrolment to the end of outcome data collection at 3 weeks
Canadian Occupational Performance Measure
Time frame: Baseline and the end of treatment at 2 weeks
Started Jul 2025 (actual). Primary completion is estimated for Aug 2026, 13 months after the start.
Of 226 non-industry interventional studies with no phase under Hemiplegia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 13 months is close to that.
Counting every sponsor, half of 231 studies reached it within 12 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.